List Of Expiring Federal Tax Provisions 2022 - 2034

Estimates Of Federal Tax Expenditures For Fiscal Years 2022-2026

Estimated Revenue Effects Of H.R. 2617, The “Consolidated Appropriations Act," As Passed By The Senate

Distributional Effects Of Selected Provisions From Subtitle A, Subtitle C, And Subtitle D Of Title I – Committee On Finance Of An Amendment In The Nature Of A Substitute To H.R. 5376, “An Act To Provide For Reconciliation Pursuant To Title II Of S. Con. Res. 14," As Passed By The Senate On August 7, 2022

Estimated Budget Effects Of The Revenue Provisions Of Title I – Committee On Finance, Of An Amendment In The Nature Of A Substitute To H.R. 5376, “An Act To Provide For Reconciliation Pursuant To Title II Of S. Con. Res. 14," As Passed By The Senate On August 7, 2022, And Scheduled For Consideration By The House Of Representatives On August 12, 2022

Estimated Budget Effects Of The Revenue Provisions Contained In The President’s Fiscal Year 2023 Budget Proposals

Present Law And Background Relating To Tax Incentives For Residential Real Estate

Present Law And Background Relating To Tax Incentives For Residential Real Estate

Overview Of The Federal Tax System As In Effect For 2022

Estimated Revenue Effects Of The House Amendment To The Senate Amendment To H.R.4346, Scheduled For Consideration By The House Of Representatives On June 24, 2022 (Rules Committee Print 117-53)

Income And Payroll Tax Offsets To Changes In Excise Tax Revenues For 2022-2032

Linking Entity Tax Returns And Wage Filings

Estimated Revenue Effects Of H.R. 3617, The “Marijuana Opportunity Reinvestment And Expungement Act (The ‘MORE Act’)," Scheduled For Consideration By The House Of Representatives On April 1, 2022 (Rules Committee Print 117-37, As Reported By The Committee On The Judiciary, With Modifications)

General Explanation Of Tax Legislation Enacted In The 116th Congress

List Of Expiring Federal Tax Provisions 2021-2031

Distributional Effects Of The Revenue Provisions Of Title XIII – Committee On Ways And Means, Of H.R. 5376, The “Build Back Better Act," As Passed By The House Of Representatives

A Distribution Of Returns By The Size Of The Tax Change For The Revenue Provisions Of Title XIII – Committee On Ways And Means, Of H.R. 5376, The “Build Back Better Act," As Passed By The House Of Representatives

Distributional Effects Of The Revenue Provisions Of Title XIII – Committee On Ways And Means, Of H.R. 5376, The “Build Back Better Act," As Passed By The House Of Representatives

Estimated Budget Effects Of The Revenue Provisions Of Title XIII – Committee On Ways And Means, Of H.R. 5376, The “Build Back Better Act," As Passed By The House Of Representatives

Estimated Budget Effects Of The Revenue Provisions Of Title XIII – Committee On Ways And Means, Of H.R. 5376, The “Build Back Better Act," As Reported By The Committee On The Budget, With Modifications (Rules Committee Print 117-18)

Distributional Effects Of The Estimated Budgetary Effects Of Subtitle B And An Amendment In The Nature Of A Substitute To The Revenue Provisions Of Subtitles F, G, H, And I Of The Budget Reconciliation Legislative Recommendations By The Committee On Ways And Means

Description Of The Chairman’s Amendment In The Nature Of A Substitute To The Committee Print Relating To Infrastructure Financing (Subtitle F), Green Energy (Subtitle G), The Social Safety Net (Subtitle H), And Prescription Drug Pricing (Subtitle J)

Estimated Budgetary Effects Of An Amendment In The Nature Of A Substitute To The Revenue Provisions Of Subtitles F, G, H, I, And J Of The Budget Reconciliation Legislative Recommendations Relating To Infrastructure Financing And Community Development, Green Energy, Social Safety Net, Responsibly Funding Our Priorities, And Drug Pricing, Scheduled For Markup By The Committee On Ways And Means On September 14, 2021

Estimated Budgetary Effects Of The Revenue Provisions Of Subtitles F, G, H, And J Of The Budget Reconciliation Legislative Recommendations Relating To Infrastructure Financing, Green Energy, Social Safety Net, And Drug Pricing